Milroy J Samuel MD

Addiction Medicine

Complete Healthcare

5888 Cleveland AveColumbus, OH 43231
Phone+1 614-882-4343
Fax+1 614-882-4664

Dr. Samuel is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Samuel's full profile Already have an account?

Summary

Dr. Milroy Samuel, based in Columbus, OH, specializes in Preventive Medicine with a subspecialty in Addiction Medicine. He completed his medical education at Meharry Medical College and an Obstetrics and Gynecology residency at Ohio State University/Mt Carmel Hospital. Since 2001, he has worked as an MD at Grant Medical Center, and had roles in GYN Surgical Services at Nationwide Children's Hospital and as an Obstetrician/Gynecologist at Ohio State University Wexner Medical Center. He has also served as a Clinical Instructor at The Ohio State University Hospital East. Dr. Samuel is experienced in addiction medicine and general gynecology. His research has been published in journals such as the Journal of Women's Health and The Journal of Reproductive Medicine. He has been involved in clinical trials related to women's health issues. Dr. Samuel has received recognitions such as Regional Top Doctor from Castle Connolly and is a Fellow of the American Congress of Obstetricians and Gynecologists.

Education & Training

Ohio State University/Mt Carmel HospitalResidency, Obstetrics and Gynecology, 1997 - 2001
Meharry Medical CollegeClass of 1997

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

OH State Medical License 1998 - 2028
FL State Medical License 2001 - 2027
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Preventive Medicine Addiction Medicine

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2016-2024
Most Compassionate Doctor American Registry
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

HOME Study: Hysteroscopic Office Myomectomy Evaluation
COMPLETED
NA
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
COMPLETED
A Multicenter Trial of the Efficacy and Safety of Diclegis® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
TERMINATED
PHASE4

Publications & Presentations

PubMed

11 citations
A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 g for the Treatment of Women and Postmenarchal Adolescen...
Steven E. Chavoustie, Janet K Gersten, Milroy J Samuel, Jane R. Schwebke
Journal of Women's Health. 2018-01-11
1 citations
Abnormal human chorionic gonadotropin levels and normal pregnancy outcomes in the ovarian hyperstimulation syndrome.
Milroy J Samuel, Clemens M Grosskinsky
The Journal of Reproductive Medicine. 2004-01-01

Authored Content

A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 G for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial VaginosisJanuary 2018